Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    18F-FMAU
Show Display Options
Rank Status Study
1 Recruiting 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
Condition: Prostate Neoplasm
Interventions: Device: CAT;   Radiation: Fluorine F 18 d-FMAU;   Other: Laboratory Biomarker Analysis;   Procedure: Multiparametric Magnetic Resonance Imaging;   Device: Positron Emission Tomography;   Device: Ultrasound
2 Suspended 18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
Condition: Malignant Neoplasm
Interventions: Radiation: fluorine F 18 d-FMAU;   Procedure: positron emission tomography;   Procedure: computed tomography
3 Suspended PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
Conditions: HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: questionnaire administration;   Radiation: fluorine F 18-clevudine;   Procedure: positron emission tomography/computed tomography

Study has passed its completion date and status has not been verified in more than two years.